These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7199305)

  • 1. [Salts of 5-methylpyrazole-3-carboxylic acid with basically substituted adenine derivatives. Identification and lipolysis inhibitory activity (author's transl)].
    Credner K; Tauscher M; Jozić L; Brenner G
    Arzneimittelforschung; 1981; 31(12):2096-100. PubMed ID: 7199305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.
    Dhalla AK; Santikul M; Smith M; Wong MY; Shryock JC; Belardinelli L
    J Pharmacol Exp Ther; 2007 Apr; 321(1):327-33. PubMed ID: 17204748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazole derivatives as partial agonists for the nicotinic acid receptor.
    van Herk T; Brussee J; van den Nieuwendijk AM; van der Klein PA; IJzerman AP; Stannek C; Burmeister A; Lorenzen A
    J Med Chem; 2003 Aug; 46(18):3945-51. PubMed ID: 12930155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of pyrazole and 4-methylpyrazole induction of cytochrome P4502E1 in rat kidney.
    Wu D; Cederbaum AI
    J Pharmacol Exp Ther; 1994 Jul; 270(1):407-13. PubMed ID: 8035340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5-Diphenyl-1H-pyrazole derivatives. XII. N-substituted 4-amino-1-(2-hydroxy- or 2-alkylaminoethyl)-3,5-diphenyl-1H-pyrazoles with local anesthetic, analgesic and platelet antiaggregating activities.
    Bruno O; Ranise A; Bondavalli F; Schenone S; D'Amico M; Falciani M; Vacca C; Filippelli A
    Farmaco; 1994 Sep; 49(9):533-40. PubMed ID: 7811347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of some novel pyrazole derivatives as potential antiinflammatory agents with minimum ulcerogenic activity.
    el-Hawash SA; el-Mallah AI
    Pharmazie; 1998 Jun; 53(6):368-73. PubMed ID: 9675765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term fasting and lipolytic activity in rat adipocytes.
    Szkudelski T; Lisiecka M; Nowicka E; Kowalewska A; Nogowski L; Szkudelska K
    Horm Metab Res; 2004 Oct; 36(10):667-73. PubMed ID: 15523590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect on lipidemia in the rat of bis-homoanalogs of adenine nucleosides].
    Gaggi R; Giovanninetti G; Cavrini V; Garuti L; Roveri P; Amorosa M; Defaye J
    Farmaco Sci; 1980 Jul; 35(7):581-9. PubMed ID: 7450047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
    Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No in vitro effects of fatty acids on glucose uptake, lipolysis or insulin signaling in rat adipocytes.
    Lundgren M; Eriksson JW
    Horm Metab Res; 2004 Apr; 36(4):203-9. PubMed ID: 15114517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
    Gastaldelli A; Casolaro A; Ciociaro D; Frascerra S; Nannipieri M; Buzzigoli E; Ferrannini E
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E225-30. PubMed ID: 19417125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromophenols coupled with nucleoside bases and brominated tetrahydroisoquinolines from the red alga Rhodomela confervoides.
    Ma M; Zhao J; Wang S; Li S; Yang Y; Shi J; Fan X; He L
    J Nat Prod; 2007 Mar; 70(3):337-41. PubMed ID: 17378529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salicylate blocks lipolytic actions of tumor necrosis factor-alpha in primary rat adipocytes.
    Zu L; Jiang H; He J; Xu C; Pu S; Liu M; Xu G
    Mol Pharmacol; 2008 Jan; 73(1):215-23. PubMed ID: 17911533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of [3H]L-glutamate uptake from L-glutamate-induced [3H]D-aspartate release by 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid and 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic acid, two conformationally constrained aspartate and glutamate analogs.
    Funicello M; Conti P; De Amici M; De Micheli C; Mennini T; Gobbi M
    Mol Pharmacol; 2004 Sep; 66(3):522-9. PubMed ID: 15322243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats.
    Dhalla AK; Santikul M; Chisholm JW; Belardinelli L; Reaven GM
    Diabetes Obes Metab; 2009 Feb; 11(2):95-101. PubMed ID: 18494808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antilipolytic action of bis(alpha-furancarboxylato)oxovanadium(IV) in adipocytes.
    Gao L; Niu Y; Liu W; Xie M; Liu X; Chen Z; Li L
    Clin Chim Acta; 2008 Feb; 388(1-2):89-94. PubMed ID: 17991430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial A1 adenosine receptor agonist regulates cardiac substrate utilization in insulin-resistant rats in vivo.
    Shearer J; Severson DL; Su L; Belardinelli L; Dhalla AK
    J Pharmacol Exp Ther; 2009 Jan; 328(1):306-11. PubMed ID: 18952888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.